The company secures Beta (Market Risk) of 1.3539 which conveys that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, LIGAND PHARM will likely underperform. Although it is extremely important to respect LIGAND PHARM INC price patterns
, it is better to be realistic regarding the information on equity historical price patterns
. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By evaluating LIGAND PHARM INC technical indicators
you can today evaluate if the expected return of 0.0% will be sustainable into the future. LIGAND PHARM INC
now secures a risk of 0.0%. Please verify LIGAND PHARM INC Standard Deviation
, Value At Risk
, as well as the relationship
between Jensen Alpha
and Semi Variance
to decide if LIGAND PHARM INC will be following its current price movements.
Over the last 30 days LIGAND PHARM INC has generated negative risk-adjusted returns adding no value to investors with long positions. Inspite fairly strong basic indicators, LIGAND PHARM is not utilizing all of its potentials. The late stock price disturbance, may contribute to short term losses for the investors.
|Fifty Two Week Low||0.0105|
|Fifty Two Week High||0.2230|